Sergei Zaslavsky

Counsel

Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.

pdf

Sergei Zaslavsky is an antitrust attorney with broad experience in trials, regulatory merger reviews, conduct investigations, antitrust audits, and antitrust counseling. Sergei effectively represents his clients by being both detail-oriented and strategic, and by studying his clients’ businesses to understand how legal questions intersect with marketplace realities. In doing this, he is able to synthesize antitrust doctrine, economics, and facts into advocacy that is both rigorous and intuitive.

Sergei is a veteran of three federal trials and one arbitration hearing. He has taken the testimony of executives, deposed numerous fact and expert witnesses, second-chaired direct and cross examinations of world-famous economists, and argued in court. In 2019, the National Law Journal named Sergei as a “DC Rising Star,” an award recognizing “the Washington, DC, region’s 40 most promising lawyers age 40 and under.”

VIEW MORE

Honors & Awards

  • Selected as one of The National Law Journal’s 2019 “DC Rising Stars”

Admissions

Bar Admissions

  • District of Columbia
  • Maryland

Education

  • Harvard University, J.D.: magna cum laude
  • Dartmouth College, A.B., Economics: summa cum laude

Professional Activities

Member

  • ABA Antitrust Law Section Leadership
  • ABA Antitrust Law Section Our Curious Amalgam Podcast

Author / Co-Author

  • Merger Control and Privacy: The Right Tool for the Job?The Deal (October 12, 2020)
  • “Chilling Tech M&A Could Hurt Competition,” Law360 (June 23, 2020)
  • “OpEd: M&A No Special Antitrust Concern During Downturns,” The Deal (May 13, 2020)
  • “Blockchain and Antitrust: How Counsel Can Mitigate Risk,” Bloomberg BNA (January 9, 2019)
  • “Deciding Between Bench and Jury Trial: Reflections After US Airways v. Sabre,” Antitrust (Fall 2017) (with Charles Diamond)
  • “Price Discrimination Markets in Merger Cases: Practical Guidance from FTC v. Sysco,” Antitrust (Fall 2016) (with Ian Simmons)

Contributing Author

  • Antitrust Law Developments Update, ABA (2019)
  • Consumer Protection Law Developments, ABA (2016)

Podcasts

  • Our Curious Amalgam, “All Bundled Up? Making Antitrust Sense of Product Bundles and Clusters,” Co-Host, ABA (2020)
  • Our Curious Amalgam, “What is the Relationship Between Privacy and Competition? A Conversation with Commissioner Noah Phillips” Co-Host, ABA (2020)
  • Our Curious Amalgam, “Breaking News Special:  Draft Vertical Merger Guidelines,” Co-Host, ABA (2020)
  • Our Curious Amalgam, “Why Does it Matter? The Role of Big Data in Antitrust” (interview with Daniel Sokol), Co-Host, ABA (2020)
  • Our Curious Amalgam, “Why the Techlash? Antitrust Policy and Big Tech” (interview with Hal Varian), Co-Host, ABA (2019)
  • Our Curious Amalgam, “What’s The State of Things:  3 Things I Keep, 3 Things I Change” (interview with Josh Wright), Co-Host, ABA (2019)
  • Our Curious Amalgam, “What is the Secret Sauce Behind Developing a Complaint” (interview with Melinda Coolidge) Co-Host, ABA (2019)
  • Our Curious Amalgam, “Can We Have Mergers Without Tears:  Understanding the Basics of Merger Review” (interview with Mike Keeley), Co-Host, ABA (2019)

Speaker

  • ABA Fundamentals of Antitrust Economics Series: Statistical Significance (November 2018)
  • ABA Consumer Protection Update (October 2015)
  • Defended AT&T and Time Warner against DOJ’s challenge of their historic merger. The trial was characterized as a “sweeping victory for AT&T” by The Wall Street Journal. United States v. AT&T Inc., 310 F. Supp. 3d 161, 164 (D.D.C. 2018), aff’d sub nom. United States v. AT&T, Inc., 916 F.3d 1029 (D.C. Cir. 2019).
  • Prepared key fact witnesses and second-chaired economic experts’ direct and cross examinations in US Airways v. Sabre, an eight-week trial that resulted in a favorable jury verdict and garnered Global Competition Review’s “Litigators of the Week” award for the O’Melveny trial team. US Airways, Inc. v. Sabre Holdings Corp., No. 11 CIV. 2725, 2017 WL 1064709 (S.D.N.Y. Mar. 21, 2017), remanded, 938 F.3d 43 (2d Cir. 2019).
  • Represented US Airways in litigation against the DOJ in its merger with American Airlines.
  • Representing a major bank in a class action involving allegations of collusion to inflate interest rates on bonds.
  • Representing Global Music Rights in antitrust litigation against the Radio Music Licensing Committee.
VIEW MORE

Alerts and Publications

The Deal: Merger Control and Privacy - The Right Tool for the Job?

十月 12, 2020

China Publishes “Unreliable Entities” Rules Targeting Foreign Enterprises

九月 22, 2020

DOJ Issues Letter Encouraging IEEE to Change Policy on Standard Essential Patents

九月 18, 2020

Hong Kong Competition Tribunal Approves First Cartel Settlement

八月 13, 2020

ABA Antitrust Law Podcast: What is the Relationship Between Privacy and Competition? A Conversation with Commissioner Noah Phillips

八月 10, 2020

Congress Reauthorizes ACPERA and Repeals Sunset Provision

七月 17, 2020

DOJ’s Prosecution of Generic Drug Companies Continues as it Announces Price-Fixing Charges Against Glenmark Pharmaceuticals, Inc.

七月 2, 2020

DOJ and FTC Issue New Vertical Merger Guidelines

七月 1, 2020

Germany’s Federal Cartel Office Calls for the EU Court of Justice’s Guidance on Important Patent Licensing Issues

六月 25, 2020

Germany’s Supreme Court Sides with National Antitrust Enforcer in Facebook Abuse of Dominance Case

六月 23, 2020

Law360: Chilling Tech M&A Could Hurt Competition

六月 23, 2020

May Price Gouging Update

六月 4, 2020

Updates on Recent US Merger Control Developments - May 2020

五月 22, 2020

New Proposed Legislation in California Increases Antitrust Scrutiny in M&A and Other Activities in the Healthcare Industry

五月 19, 2020

The Deal: M&A No Special Antitrust Concern During Downturns

五月 13, 2020

COVID-19 Antitrust M&A Considerations

五月 7, 2020

Collusion in the Healthcare Industry: DOJ Charges Oncology Group for its Participation in a Criminal Antitrust Conspiracy

五月 6, 2020

Price Gouging Update—April 2020

四月 30, 2020

Gun-Jumping Concerns for Pending Transactions When There Is No Such Thing as “Ordinary Course of Business”

四月 27, 2020

The Failing Firm Merger Defense in Times of Economic Turmoil: Past Lessons and the COVID-19 Crisis

四月 23, 2020

Antitrust Agencies Watch for Labor Market Collusion in the Healthcare Industry

四月 20, 2020

DOJ and FTC on Alert for Anticompetitive Conduct in Labor Markets for COVID-19 Essential Workers

四月 15, 2020

Nationwide Shortages Open New Frontiers in Fight Against COVID-19-Related Price Gouging

四月 14, 2020

Hong Kong Competition Commission Consults on Proposed Commitments Offered by Online Travel Agents to Remove Parity Clauses from Agreements with Accommodation Providers

四月 9, 2020

China Adopts Antitrust Enforcement Policy to Fight COVID-19 and Spur Economic Recovery

四月 8, 2020

Antitrust Implications of the President’s Invocation of the Defense Production Act

四月 2, 2020

Department of Health and Human Services Triggers Price Gouging and Hoarding Provisions of Defense Production Act

四月 1, 2020

Hong Kong Competition Commission Issues Statement on the Application of the Competition Rules to Cooperation Agreements Between Companies Responding to the COVID-19 Pandemic

三月 30, 2020

Competitor Collaborations and Communications in Time of Crisis: Practical Guidance

三月 26, 2020

Antitrust Agencies Provide Guidance for Competitor Collaborations in Healthcare Sector as COVID-19 Outbreak Deepens

三月 25, 2020

European Antitrust in the Time of COVID-19

三月 25, 2020

ABA Antitrust Law Podcast: What’s The State of Things- 3 Things I Keep, 3 Things I Change

十一月 4, 2019

ABA Antitrust Law Podcast: Understanding the Basics of Merger Review

八月 26, 2019

Blockchain and Antitrust: Emerging Issues for Businesses

二月 7, 2019

Blockchain and Antitrust: How Counsel Can Mitigate Risk

一月 9, 2019

In the News

Press Releases